Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health, and dermatological conditions. Its product portfolio includes Lumacyn, Regenacyn, Reliefacyn, Gramaderm, Epicyn, Levicyn, Celacyn, Pediacyn, Microcyn, Ocucyn, Ocudox, Sinudox, Microdacyn60, Podiacyn, MicrocynAH, MicrocynVS, Nanocyn, Acuicyn, MucoClyns, and Endocyn. The company operates in the United States, Europe, Asia, Latin America, and internationally. Formerly known as Oculus Innovative Sciences, Inc., it changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Incorporated in 1999, it is based in Boulder, Colorado.